Related Experiment Video
Updated: Feb 2, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Artificial MicroRNA-Mediated Inhibition of Japanese Encephalitis Virus Replication in Neuronal Cells
Himani Sharma1,2, Aarti Tripathi1, Bharti Kumari1
11 Vaccine and Infectious Disease Research Center (VIDRC), Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Abstract:
Artificial microRNA (amiRNA)-mediated inhibition of viral replication has recently gained importance as a strategy for antiviral therapy. In this study, we evaluated the benefit of using the amiRNA vector against Japanese encephalitis virus (JEV). We designed three single amiRNA sequences against the consensus sequence of 3' untranslated region (3'UTR) of JEV and tested their efficacy against cell culture-grown JEV Vellore strain (P20778) in neuronal cells. The binding ability of three amiRNAs on 3'UTR region was tested in vitro in HEK293T cells using a JEV 3'UTR tagged with luciferase reporter vector. Transient transfection of amiRNAs was nontoxic to cells as evident from the MTT assay and caused minimal induction in interferon-stimulated gene expression. Furthermore, our result suggested that transient expression of two amiRNAs (amiRNA #1 and amiRNA #2) significantly reduced intracellular viral RNA and nonstructural 1 (NS1) protein, as well as diminished infectious viral particle release up to 95% in the culture supernatant as evident from viral plaque reduction assay. Overall, our results indicated that RNA interference based on amiRNAs targeting viral conserved regions at 3'UTR was a useful approach for improvements of nucleic acid inhibitors against JEV.
Insights
Artificial microRNAs effectively inhibit Japanese encephalitis virus (JEV) replication by targeting conserved 3' untranslated regions. This RNA interference approach significantly reduces viral RNA, proteins, and infectious particles, offering a promising antiviral strategy.
Area of Science:
- Virology
- Molecular Biology
- Antiviral Therapy
Background:
- Artificial microRNAs (amiRNAs) are emerging as a potent strategy for inhibiting viral replication.
- Japanese encephalitis virus (JEV) poses a significant public health threat, necessitating novel therapeutic approaches.
Purpose of the Study:
- To evaluate the efficacy of amiRNA-mediated inhibition against Japanese encephalitis virus (JEV).
- To assess the potential of targeting the 3' untranslated region (3'UTR) of JEV for antiviral therapy.
Main Methods:
- Designed three amiRNA sequences targeting the conserved 3'UTR of JEV.
- Tested amiRNA binding affinity in vitro using a luciferase reporter assay.
- Assessed amiRNA efficacy in neuronal cells through viral RNA quantification, protein analysis (NS1), and plaque reduction assays.
Main Results:
- Transient amiRNA transfection was non-toxic and minimally induced interferon-stimulated genes.
- Two amiRNAs (amiRNA #1 and #2) significantly reduced intracellular viral RNA and NS1 protein levels.
- Infectious viral particle release was diminished by up to 95% in the supernatant.
Conclusions:
- RNA interference utilizing amiRNAs targeting conserved JEV 3'UTR regions is an effective antiviral strategy.
- This approach shows promise for developing improved nucleic acid-based inhibitors against JEV.
More Related Videos
09:17Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits
Published on: March 14, 2018
12:20Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Related Concept Videos
MicroRNAs
What are Viruses?
The DNA Replication Fork
Chromosome Replication
Replicative Cell Senescence
DNA Replication
Replication in Prokaryotes
DNA replication...